Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 9, 2026.
Asensus Surgical is a company within the Medical Devices category. Asensus Surgical is a medical technology company focused on digitalizing the interface between surgeons and patients through its Senhance Surgical System. The system integrates augmented intelligence to provide surgeons with haptic feedback, eye-tracking camera control, and 3D vision, aiming to improve surgical outcomes and efficiency.
Asensus Surgical was founded in 1988 (as TransEnterix) and is headquartered in Research Triangle Park, NC, USA.
Asensus Surgical is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Asensus Surgical is Strong.
AI models classify Asensus Surgical as a Challenger. AI names competitors first.
Asensus Surgical appeared in 5 of 5 sampled buyer-intent queries (100%). Asensus Surgical is highly discoverable for direct brand and product searches, as well as general industry terms. There are no significant gaps in primary search visibility.
Asensus Surgical is perceived as an innovator in the robotic surgery space, particularly for its focus on augmented intelligence and surgeon assistance rather than full automation. There's a consistent message about improving surgical outcomes and reducing variability. Key gap: No major discrepancies found; descriptions generally align on the company's core technology and market positioning.
Of 3 key facts verified about Asensus Surgical, 3 are well-documented (likely accurate across AI models), 0 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The company's main vulnerability is competing with larger, more established players in the robotic surgery market who have significantly greater resources and market penetration.
Buyers evaluating Asensus Surgical typically ask AI models about "Asensus Surgical", "Senhance Surgical System", "robotic surgery companies", and 3 similar queries.
Asensus Surgical's core products are Senhance Surgical System, which includes the surgical robot, instruments, and digital tools enabled by augmented intelligence..
Asensus Surgical uses Capital equipment sale for the system, likely followed by recurring revenue from instrument sales, service contracts, and per-procedure fees..
Asensus Surgical serves Hospitals and surgical centers globally, primarily targeting general surgery, gynecology, urology, and thoracic procedures..
Asensus Surgical Integration of augmented intelligence (haptic feedback, eye-tracking, 3D vision) with reusable instruments, aiming for a more intuitive and cost-effective approach to robotic surgery compared to some competitors.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Challenger
Official website: https://asensussurgical.ai/
Last analyzed: August 9, 2026
Founded: 1988 (source: official website)
Headquarters: Research Triangle Park, NC, USA (source: official website)
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile